\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\ \(73\)\
\-\ steroid\\ therapy\\ for\\ symptomatic\\ or\\ progressive\\ disease\\.\ \(0\)\
\-\ bilateral\\ hilar\\ adenopathy\\ and\\ reticular\\ interstitial\\ disease\\.\\ \\ expected\\ postoperative\\ median\\ sternotomy\\ changes\\.\ \(0\)\
\-\ sarcoid\ \(163\)\
\-\ sarcoid\ \(163\)\
\-\ lymphoma\ \(373\)\
\-\ infectious\\ etiology\ \(7\)\
\-\ 63\\ year\\ male\\ with\\ 5\\ year\\ history\\ of\\ sarcoid\\,\\ asymptomatic\ \(1\)\
\-\ this\\ is\\ an\\ atypical\\ presentation\\ due\\ to\\ the\\ patient\\'s\\ age\\.\\ however\\,\\ he\\ is\\ largely\\ asymptomatic\\ as\\ are\\ approximately\\ 50\\ \\%\\ of\\ people\\ who\\ are\\ diagnosed\\ incidentaly\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ sarcoid\\:\\ 0\\.18791578393385075\ \(0\)\
\-\ incidentaly\\:\\ 0\\.1160338749058079\ \(0\)\
\-\ sternotomy\\:\\ 0\\.08464495237243334\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.08253121137131678\ \(0\)\
\-\ people\\:\\ 0\\.08114320297196212\ \(0\)\
\-\ reticular\\:\\ 0\\.07939174122778593\ \(0\)\
\-\ largely\\:\\ 0\\.07939174122778593\ \(0\)\
\-\ postoperative\\:\\ 0\\.07093386888937771\ \(0\)\
\-\ median\\:\\ 0\\.07063310590083725\ \(0\)\
\-\ 63\\:\\ 0\\.06768544257229683\ \(0\)\
\-\ steroid\\:\\ 0\\.06444933329660468\ \(0\)\
\-\ hilar\\:\\ 0\\.06133899781310654\ \(0\)\
\-\ interstitial\\:\\ 0\\.05972556336766946\ \(0\)\
\-\ expected\\:\\ 0\\.0594508296258425\ \(0\)\
\-\ adenopathy\\:\\ 0\\.0543554732838606\ \(0\)\
\-\ atypical\\:\\ 0\\.05290758050871364\ \(0\)\
\-\ infectious\\:\\ 0\\.05248364096376911\ \(0\)\
\-\ etiology\\:\\ 0\\.05167173418143818\ \(0\)\
\-\ symptomatic\\:\\ 0\\.048499763209917314\ \(0\)\
\-\ progressive\\:\\ 0\\.048249130214904325\ \(0\)\
\-\ 50\\:\\ 0\\.04644282880919721\ \(0\)\
\-\ diagnosed\\:\\ 0\\.04488850223992865\ \(0\)\
\-\ presentation\\:\\ 0\\.04204858049272975\ \(0\)\
\-\ available\\:\\ 0\\.041038843554854244\ \(0\)\
\-\ disease\\:\\ 0\\.03990678689187726\ \(0\)\
\-\ approximately\\:\\ 0\\.03776882609365118\ \(0\)\
\-\ age\\:\\ 0\\.03715586179349009\ \(0\)\
\-\ 5\\:\\ 0\\.035716577463488046\ \(0\)\
\-\ changes\\:\\ 0\\.034986399660500864\ \(0\)\
\-\ lymphoma\\:\\ 0\\.0348885519198498\ \(0\)\
\-\ he\\:\\ 0\\.03405981917190028\ \(0\)\
\-\ however\\:\\ 0\\.03399097222281529\ \(0\)\
\-\ are\\:\\ 0\\.03328211064370291\ \(0\)\
\-\ therapy\\:\\ 0\\.03263772566058019\ \(0\)\
\-\ due\\:\\ 0\\.03257538789932628\ \(0\)\
\-\ who\\:\\ 0\\.031828120130595744\ \(0\)\
\-\ bilateral\\:\\ 0\\.029625967561634912\ \(0\)\
\-\ \\%\\:\\ 0\\.028476014762085822\ \(0\)\
\-\ year\\:\\ 0\\.027317293407797563\ \(0\)\
\-\ \\'s\\:\\ 0\\.026914951690957784\ \(0\)\
\-\ male\\:\\ 0\\.022074364826963903\ \(0\)\
\-\ as\\:\\ 0\\.018465392941344683\ \(0\)\
\-\ not\\:\\ 0\\.017640266739170504\ \(0\)\
\-\ an\\:\\ 0\\.016880926632638998\ \(0\)\
\-\ history\\:\\ 0\\.016860207681529762\ \(0\)\
\-\ is\\:\\ 0\\.01606545081099216\ \(0\)\
\-\ or\\:\\ 0\\.014307467842338679\ \(0\)\
\-\ this\\:\\ 0\\.013730531618773328\ \(0\)\
\-\ patient\\:\\ 0\\.012237027584519828\ \(0\)\
\-\ for\\:\\ 0\\.01041583069489593\ \(0\)\
\-\ \\,\\:\\ 0\\.007734573300493925\ \(0\)\
\-\ to\\:\\ 0\\.006100972977756946\ \(0\)\
\-\ of\\:\\ 0\\.0033286800227996694\ \(0\)\
\-\ and\\:\\ 0\\.002571557224745978\ \(0\)\
\-\ \\.\\:\\ 0\\.002535681149810448\ \(0\)\
\-\ the\\:\\ 0\\.0019749897814803686\ \(0\)\
\-\ with\\:\\ 0\\.0016714882298555676\ \(0\)\
